Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
5.25
-0.19 (-3.49%)
Sep 10, 2026, 11:44 AM CST
SHE:300039 Revenue
Shanghai Kaibao Pharmaceutical CO.,Ltd had revenue of 179.67M CNY in the quarter ending June 30, 2026, a decrease of -11.93%. This brings the company's revenue in the last twelve months to 1.01B, down -19.05% year-over-year. In the year 2025, Shanghai Kaibao Pharmaceutical CO.,Ltd had annual revenue of 1.15B, down -21.76%.
Revenue (ttm)
1.01B
Revenue Growth
-19.05%
P/S Ratio
5.63
Revenue / Employee
844.55K
Employees
1,197
Market Cap
5.69B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.15B | -320.66M | -21.76% |
| Dec 31, 2024 | 1.47B | -120.73M | -7.57% |
| Dec 31, 2023 | 1.59B | 475.20M | 42.47% |
| Jan 1, 2023 | 1.12B | 18.27M | 1.66% |
| Jan 1, 2022 | 1.10B | 192.57M | 21.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| HPGC Renmintongtai Pharmaceutical | 10.64B |
| Guizhou Xinbang Pharmaceutical | 5.24B |
| Hunan Jiudian Pharmaceutical | 2.89B |
| Tianjin Tianyao Pharmaceuticals | 2.63B |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.42B |
| Shandong Wit Dyne Health | 1.91B |
| Bide Pharmatech | 1.38B |
| Wanbangde Pharmaceutical Holding Group | 1.13B |